Drug profile · INN
miglustat
MIGLUSTAT DIPHARMA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
miglustat (MIGLUSTAT DIPHARMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN miglustat
Brand MIGLUSTAT DIPHARMA
Route ORAL
Formulation CAPSULE
ATC code A16AX06
Frequently asked questions
What is miglustat?
miglustat (MIGLUSTAT DIPHARMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for miglustat?
MIGLUSTAT DIPHARMA is a marketed brand name for miglustat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of miglustat?
miglustat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.